Cargando…
ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1
Enhanced glycolysis has been identified as a hallmark of cancer. As a novel oncogene, ACTL6A is aberrantly amplified in several types of human cancers and has been shown to regulate tumor growth and progression. However, the roles of ACTL6A in the development of ovarian cancer and the regulation of...
Autores principales: | Zhang, Jiawen, Zhang, Jing, Wei, Yingze, Li, Qingxian, Wang, Qingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813335/ https://www.ncbi.nlm.nih.gov/pubmed/31649264 http://dx.doi.org/10.1038/s41419-019-2050-y |
Ejemplares similares
-
Clinicopathological and immunological characterization of RNA m(6)A methylation regulators in ovarian cancer
por: Wang, Qingying, et al.
Publicado: (2020) -
Profile of follicle-stimulating hormone and polymorphism of follicle-stimulating hormone receptor in Madrasin cattle with ovarian hypofunction
por: Utomo, Budi, et al.
Publicado: (2020) -
PTCSC3‐mediated glycolysis suppresses thyroid cancer progression via interfering with PGK1 degradation
por: Jiang, Bo, et al.
Publicado: (2021) -
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes
por: Gou, Rui, et al.
Publicado: (2021) -
Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI
por: Wu, Song-Tao, et al.
Publicado: (2020)